MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Extended long-term follow-up of adaptive deep brain stimulation in Parkinson’s disease

    T. Herrington, A. Ramirez-Zamora, M. Beudel, S. Little, J. Ostrem, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, N. Sarangmat, M. Gostkowski, L. Tonder, Y. Tan, R. Summers, T. Goble, S. Stanslaski, H. Bronte-Stewart (Boston, USA)

    Objective: To evaluate the extended long-term durability, programming stability, and safety of adaptive deep brain stimulation (aDBS) in people with Parkinson’s disease (PD). Background: Adaptive DBS is a recently available enhancement to continuous DBS (cDBS) that dynamically adjusts stimulation amplitude based on neural…
  • 2026 International Congress

    fMRI Activity during Working Memory Manipulation is Associated with Caudate Integrity in Early Parkinson’s Disease

    K. Giehl, H. Theis, A. Asendorf, M. Banwinkler, V. Dzialas, R. Lubomierski, M. Hönig, T. van Eimeren (Juelich, Germany)

    Objective: This study aimed to determine whether reduced dopaminergic integrity and increased iron deposition in the caudate are associated with altered BOLD activation during high…
  • 2026 International Congress

    Poststroke Movement Disorders: Clinical, Neuroimaging and Electrophysiological correlates

    S. Yellaturi, S. Pandey (Faridabad, India)

    Objective: To study the phenotypes of post stroke movement disorders (PSMDs) and examine their correlations with neuroimaging and electrophysiology. Background: Different stroke locations lead to…
  • 2026 International Congress

    TMEM106B Fibrils Potentiate Pathological α-Synuclein Aggregation in Parkinson’s Disease

    WB. Zhao, WB. Yu, C. Liu, J. Wang, Y. Fan (Shanghai, China)

    Objective: To determine whether transmembrane protein 106B (TMEM106B) fibrils promote α-synuclein (α-syn) aggregation and to elucidate the molecular basis of this interaction in Parkinson’s disease…
  • 2026 International Congress

    Optimizing Institutional Long-Term Care in Advanced Parkinson’s and Other Neurodegenerative Disease: The OPTICARE Study

    J. Stuempel, J. Braun, J. Wolters, C. Woopen, B. Schmitz-Luhn (Bonn, Germany)

    Objective: To analyze and improve institutional long-term care (LTC) structures for patients with advanced PD and AD by identifying modifiable determinants of care integration, QoL,…
  • 2026 International Congress

    Safety and Effect of Ecopipam During the First 8 Weeks of Treatment for Tourette Syndrome: A Post Hoc Analysis

    K. Tomczak, T. Katz, J. Flatt, G. Karkanias, S. Wanaski, T. Cunniff, D. Gilbert (Boston, USA)

    Objective: To assess the safety profile and effect of ecopipam, a selective dopamine D1 receptor antagonist, during the first 8 weeks of therapy for Tourette…
  • 2026 International Congress

    Effects of Modafinil on Motor and Non‑Motor Outcomes in Parkinson’s Disease: A Meta‑Analysis of Randomized, Placebo‑Controlled Trials

    A. Lin, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Cincinnati, USA)

    Objective: To determine the efficacy and safety of modafinil on motor and non-motor outcomes in Parkinson’s disease (PD) using evidence exclusively from randomized placebo‑controlled clinical…
  • 2026 International Congress

    Association between Sleep Behaviors and Age at Onset of Parkinson’s Disease

    N. Zhou, M. Fang, L. He, T. Shao, Z. Liu, B. Liu, R. Li, W. Li (Beijing, China)

    Objective: To investigate the associations between multiple sleep behaviors and the age at onset (AAO) of Parkinson’s disease (PD) using the UK Biobank. Background: Sleep…
  • 2026 International Congress

    Disease Burden Profile of Patients with Spinocerebellar Ataxia in China: A Real-World Registry Study (2025)

    LY. Lu, LF. Zhang, Y. Huang (Beijing, China)

    Objective: To analyze the clinical characteristics, diagnostic pathways, and socioeconomic impact on newly registered SCA patients in China during the year 2025. Background: Spinocerebellar ataxia…
  • 2026 International Congress

    Characteristics of participants of the Australian National Disability Insurance Scheme with Parkinson’s disease

    J. Mcginley, K. Bower, V. Mcconvey, M. Callisaya, A. Khan, M. Ho, D. Shen, S. Fernando, M. Klaic, S. Soh (Parkville, Australia)

    Objective: To evaluate the demographic characteristics, goals and funding of participants with Parkinson’s disease (PD) in the Australian National Disability Insurance Scheme (NDIS). Background: The…
  • « Previous Page
  • 1
  • …
  • 204
  • 205
  • 206
  • 207
  • 208
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley